ClinicalTrials.Veeva

Menu

The Influence of Talocrural Manipulation on Proprioception in Stroke

B

Bitlis Eren University

Status

Enrolling

Conditions

Stroke

Treatments

Other: Placebo Talocrural Joint Manipulation
Other: Talocrural Joint Manipulation

Study type

Interventional

Funder types

Other

Identifiers

NCT06849076
BEUFTR-6

Details and patient eligibility

About

The aim of the study is to investigate the effect of talocrural joint manipulation on the ankle proprioception of patients with stroke.

Full description

The study, utilizing a randomized crossover design, is planned to be conducted on a minimum of 26 patients with stroke who meet the inclusion and exclusion criteria. Patients included in the study will be randomly assigned to receive both placebo talocrural joint manipulation and talocrural joint manipulation interventions.

Enrollment

26 estimated patients

Sex

All

Ages

45 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Two months or longer elapsed since the stroke,
  2. A Mini-Mental State Examination score of 24 or higher,
  3. Being between 45 and 75 years of age,
  4. Having a Brunnstrom stage of 4 or above

Exclusion criteria

  1. The presence of severe osteoarthritis in the lower extremity,
  2. The presence of cancer or diabetic neuropathy,
  3. The presence of vestibular disorder,
  4. The presence of lower extremity ulceration or amputation,
  5. Hemodynamic instability,
  6. The presence of other neurological disorders (such as multiple sclerosis, Parkinson's disease),
  7. Having experienced an acute lower extremity injury in the last six weeks,
  8. History of lower extremity surgery
  9. Lack of available range of motion values required for the ankle proprioception test

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

26 participants in 2 patient groups, including a placebo group

Placebo Talocrural Joint Manipulation Group
Placebo Comparator group
Description:
In this group, patients will receive placebo talocrural joint manipulation. The application will be similar to that in the experimental group, however, hands will be positioned to avoid creating traction or manipulation force, and this position will be maintained for 20 seconds.
Treatment:
Other: Placebo Talocrural Joint Manipulation
Talocrural Joint Manipulation Group
Experimental group
Description:
In this group, talocrural joint manipulation will be applied. After positioning the patient, high velocity low amplitude traction will be applied.
Treatment:
Other: Talocrural Joint Manipulation

Trial contacts and locations

1

Loading...

Central trial contact

burak mavuş, M.Sc.; ömer dursun, Asst. Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems